To characterise type 2 diabetes (T2D) associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D cases and 132,532 controls of European ancestry after imputation using the 1000 Genomes multi-ethnic reference panel. Promising association signals were followed-up in additional data sets (of 14,545 or 7,397 T2D cases and 38,994 or 71,604 controls). We identified 13 novel T2D-associated loci (p<5×10(-8)), including variants near the GLP2R, GIP, and HLA-DQA1 genes. Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci. Despite substantially increased sample size and more complete coverage of low-frequency vari...
To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we ...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we...
To characterise type 2 diabetes (T2D) associated variation across the allele frequency spectrum, we ...
To characterise type 2 diabetes (T2D) associated variation across the allele frequency spectrum, we ...
To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we ...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we...
To characterise type 2 diabetes (T2D) associated variation across the allele frequency spectrum, we ...
To characterise type 2 diabetes (T2D) associated variation across the allele frequency spectrum, we ...
To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we ...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we...